Lung	B:C0024128
Transplantation	I:C0024128
for	O
FLNA	O
-	O
Associated	O
Progressive	O
Lung	O
Disease	I:C0024115

Lung	O
Transplantation	I:C0024128
for	O
FLNA	B:C1414635
-	O
Associated	O
Progressive	O
Lung	O
Disease	I:C0024115

Lung	O
Transplantation	I:C0024128
for	O
FLNA	O
-	O
Associated	O
Progressive	O
Lung	B:C0024115
Disease	I:C0024115

To	O
describe	O
a	O
series	O
of	O
patients	O
with	O
pathogenic	O
variants	O
in	O
FLNA	O
and	O
progressive	O
lung	B:C0024115
disease	I:C0024115
necessitating	O
lung	O
transplantation	I:C0024128
.	O

To	O
describe	O
a	O
series	O
of	O
patients	O
with	O
pathogenic	O
variants	O
in	O
FLNA	O
and	O
progressive	O
lung	O
disease	I:C0024115
necessitating	O
lung	B:C0024128
transplantation	I:C0024128
.	O

We	O
conducted	O
a	O
retrospective	O
chart	O
review	O
of	O
6	O
female	O
infants	O
with	O
heterozygous	O
presumed	O
loss	B:C0243095
-	I:C0243095
of	I:C0243095
-	I:C0243095
function	I:C0243095
pathogenic	O
variants	O
in	O
FLNA	O
whose	O
initial	O
presentation	O
was	O
early	O
and	O
progressive	O
respiratory	O
failure	I:C1145670
.	O

We	O
conducted	O
a	O
retrospective	O
chart	O
review	O
of	O
6	O
female	O
infants	O
with	O
heterozygous	O
presumed	O
loss	O
-	I:C0243095
of	I:C0243095
-	I:C0243095
function	I:C0243095
pathogenic	O
variants	O
in	O
FLNA	O
whose	O
initial	O
presentation	O
was	O
early	B:C3807376
and	O
progressive	O
respiratory	O
failure	I:C1145670
.	O

We	O
conducted	O
a	O
retrospective	O
chart	O
review	O
of	O
6	O
female	O
infants	O
with	O
heterozygous	O
presumed	O
loss	O
-	I:C0243095
of	I:C0243095
-	I:C0243095
function	I:C0243095
pathogenic	O
variants	O
in	O
FLNA	O
whose	O
initial	O
presentation	O
was	O
early	O
and	O
progressive	O
respiratory	B:C1145670
failure	I:C1145670
.	O

Each	O
patient	O
received	O
lung	B:C0024128
transplantation	I:C0024128
at	O
an	O
average	O
age	O
of	O
11	O
months	O
(	O
range	O
,	O
5	O
-	O
15	O
months	O
)	O
.	O

All	O
patients	O
had	O
pulmonary	B:C2973725
arterial	I:C2973725
hypertension	I:C2973725
and	O
chronic	O
respiratory	I:C0264492
failure	I:C0264492
requiring	O
tracheostomy	O
and	O
escalating	O
levels	O
of	O
ventilator	O
support	I:C0087153
before	O
transplantation	O
.	O

All	O
patients	O
had	O
pulmonary	O
arterial	I:C2973725
hypertension	I:C2973725
and	O
chronic	B:C0264492
respiratory	I:C0264492
failure	I:C0264492
requiring	O
tracheostomy	O
and	O
escalating	O
levels	O
of	O
ventilator	O
support	I:C0087153
before	O
transplantation	O
.	O

All	O
patients	O
had	O
pulmonary	O
arterial	I:C2973725
hypertension	I:C2973725
and	O
chronic	O
respiratory	I:C0264492
failure	I:C0264492
requiring	O
tracheostomy	B:C0040590
and	O
escalating	O
levels	O
of	O
ventilator	O
support	I:C0087153
before	O
transplantation	O
.	O

All	O
patients	O
had	O
pulmonary	O
arterial	I:C2973725
hypertension	I:C2973725
and	O
chronic	O
respiratory	I:C0264492
failure	I:C0264492
requiring	O
tracheostomy	O
and	O
escalating	O
levels	O
of	O
ventilator	B:C0087153
support	I:C0087153
before	O
transplantation	O
.	O

All	O
patients	O
had	O
pulmonary	O
arterial	I:C2973725
hypertension	I:C2973725
and	O
chronic	O
respiratory	I:C0264492
failure	I:C0264492
requiring	O
tracheostomy	O
and	O
escalating	O
levels	O
of	O
ventilator	O
support	I:C0087153
before	O
transplantation	B:C0024128
.	O

All	O
6	O
patients	O
survived	O
initial	O
lung	B:C0024128
transplantation	I:C0024128
;	O
however	O
,	O
1	O
patient	O
died	O
after	O
a	O
subsequent	O
heart	O
-	I:C0018833
lung	I:C0018833
transplant	I:C0018833
.	O

All	O
6	O
patients	O
survived	O
initial	O
lung	O
transplantation	I:C0024128
;	O
however	O
,	O
1	O
patient	O
died	B:C0011065
after	O
a	O
subsequent	O
heart	O
-	I:C0018833
lung	I:C0018833
transplant	I:C0018833
.	O

All	O
6	O
patients	O
survived	O
initial	O
lung	O
transplantation	I:C0024128
;	O
however	O
,	O
1	O
patient	O
died	O
after	O
a	O
subsequent	O
heart	B:C0018833
-	I:C0018833
lung	I:C0018833
transplant	I:C0018833
.	O

The	O
remaining	O
5	O
patients	O
are	O
living	O
unrestricted	O
lives	O
on	O
chronic	B:C4048329
immunosuppression	I:C4048329
at	O
most	O
recent	O
follow	I:C1522577
-	I:C1522577
up	I:C1522577
(	O
range	O
,	O
19	O
months	O
to	O
11.3	O
years	O
post	O
-	O
transplantation	O
)	O
.	O

The	O
remaining	O
5	O
patients	O
are	O
living	O
unrestricted	O
lives	O
on	O
chronic	O
immunosuppression	I:C4048329
at	O
most	O
recent	B:C1522577
follow	I:C1522577
-	I:C1522577
up	I:C1522577
(	O
range	O
,	O
19	O
months	O
to	O
11.3	O
years	O
post	O
-	O
transplantation	O
)	O
.	O

The	O
remaining	O
5	O
patients	O
are	O
living	O
unrestricted	O
lives	O
on	O
chronic	O
immunosuppression	I:C4048329
at	O
most	O
recent	O
follow	I:C1522577
-	I:C1522577
up	I:C1522577
(	O
range	O
,	O
19	O
months	O
to	O
11.3	O
years	O
post	O
-	O
transplantation	B:C0024128
)	O
.	O

However	O
,	O
in	O
all	O
patients	O
,	O
severe	O
ascending	B:C0345049
aortic	I:C0345049
dilation	I:C0345049
has	O
been	O
observed	O
with	O
aortic	O
regurgitation	I:C0003504
.	O

However	O
,	O
in	O
all	O
patients	O
,	O
severe	O
ascending	O
aortic	I:C0345049
dilation	I:C0345049
has	O
been	O
observed	O
with	O
aortic	B:C0003504
regurgitation	I:C0003504
.	O

Respiratory	B:C1145670
failure	I:C1145670
secondary	O
to	O
progressive	O
obstructive	O
lung	I:C0600260
disease	I:C0600260
during	O
infancy	O
may	O
be	O
the	O
presenting	O
phenotype	O
of	O
FLNA	O
-	I:C1868720
associated	I:C1868720
periventricular	I:C1868720
nodular	I:C1868720
heterotopia	I:C1868720
.	O

Respiratory	O
failure	I:C1145670
secondary	O
to	O
progressive	O
obstructive	B:C0600260
lung	I:C0600260
disease	I:C0600260
during	O
infancy	O
may	O
be	O
the	O
presenting	O
phenotype	O
of	O
FLNA	O
-	I:C1868720
associated	I:C1868720
periventricular	I:C1868720
nodular	I:C1868720
heterotopia	I:C1868720
.	O

Respiratory	O
failure	I:C1145670
secondary	O
to	O
progressive	O
obstructive	O
lung	I:C0600260
disease	I:C0600260
during	O
infancy	O
may	O
be	O
the	O
presenting	O
phenotype	O
of	O
FLNA	B:C1868720
-	I:C1868720
associated	I:C1868720
periventricular	I:C1868720
nodular	I:C1868720
heterotopia	I:C1868720
.	O

We	O
describe	O
a	O
cohort	B:C0599755
of	O
patients	O
with	O
progressive	O
respiratory	O
failure	I:C1145670
related	O
to	O
a	O
pathogenic	O
variant	O
in	O
FLNA	O
and	O
present	O
lung	O
transplantation	I:C0024128
as	O
a	O
viable	O
therapeutic	I:C0087111
option	I:C0087111
for	O
this	O
group	O
of	O
patients	O
.	O

We	O
describe	O
a	O
cohort	O
of	O
patients	O
with	O
progressive	O
respiratory	B:C1145670
failure	I:C1145670
related	O
to	O
a	O
pathogenic	O
variant	O
in	O
FLNA	O
and	O
present	O
lung	O
transplantation	I:C0024128
as	O
a	O
viable	O
therapeutic	I:C0087111
option	I:C0087111
for	O
this	O
group	O
of	O
patients	O
.	O

We	O
describe	O
a	O
cohort	O
of	O
patients	O
with	O
progressive	O
respiratory	O
failure	I:C1145670
related	O
to	O
a	O
pathogenic	O
variant	O
in	O
FLNA	O
and	O
present	O
lung	B:C0024128
transplantation	I:C0024128
as	O
a	O
viable	O
therapeutic	I:C0087111
option	I:C0087111
for	O
this	O
group	O
of	O
patients	O
.	O

We	O
describe	O
a	O
cohort	O
of	O
patients	O
with	O
progressive	O
respiratory	O
failure	I:C1145670
related	O
to	O
a	O
pathogenic	O
variant	O
in	O
FLNA	O
and	O
present	O
lung	O
transplantation	I:C0024128
as	O
a	O
viable	B:C0087111
therapeutic	I:C0087111
option	I:C0087111
for	O
this	O
group	O
of	O
patients	O
.	O

